These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28225167)

  • 1. Symmetrical drug-related intertriginous and flexural exanthema possibly due to thiamine disulfide.
    Hattori Y; Matsuyama K; Shu E; Kanoh H; Seishima M
    J Dermatol; 2017 Jun; 44(6):e115-e116. PubMed ID: 28225167
    [No Abstract]   [Full Text] [Related]  

  • 2. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
    [No Abstract]   [Full Text] [Related]  

  • 3. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Magnolo N; Metze D; Ständer S
    J Dtsch Dermatol Ges; 2017 Jun; 15(6):657-659. PubMed ID: 28514083
    [No Abstract]   [Full Text] [Related]  

  • 5. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
    Choi MJ; Oh SH; Cho SB
    Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
    [No Abstract]   [Full Text] [Related]  

  • 6. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 7. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine.
    Liu J; Li LF
    J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both?
    Özkaya E; Babuna G
    Pediatr Dermatol; 2011; 28(6):711-714. PubMed ID: 22082466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
    Moreira C; Cruz MJ; Cunha AP; Azevedo F
    An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
    [No Abstract]   [Full Text] [Related]  

  • 13. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
    Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
    Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathological Spectrum and Immunophenotypic Characterization of Symmetrical Drug-Related Intertriginous and Flexural Exanthema.
    Muresan AM; Metze D; Böer-Auer A; Braun SA
    Am J Dermatopathol; 2021 Feb; 43(2):103-111. PubMed ID: 32618703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing in cutaneous reactions caused by carbamazepine.
    Alanko K
    Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
    Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
    Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
    [No Abstract]   [Full Text] [Related]  

  • 18. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
    Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
    Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug.
    Kumar S; Bhale G; Brar BK
    Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833
    [No Abstract]   [Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema (baboon syndrome) with fever induced by oral cloxacillin: does fever confound the diagnosis?
    Chong WS; Lim HL
    J Dermatol; 2010 Sep; 37(9):830-2. PubMed ID: 20883371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.